Liberty Leaf Signs Definitive Contract with Cannvas to be its Exclusive Cannabis Education Provider
Customized Educational Content Powered by Physician-Backed Cannvas.Me Platform
Vancouver, British Columbia / May 28, 2019 – Liberty Leaf Holdings Ltd. (CSE: LIB) (OTC: LIBFF) (FSE: HN3P) (“Liberty Leaf” or the “Company”) is pleased to announce it has signed an agreement with Cannvas MedTech Inc. (“Cannvas”) (CSE: MTEC) (Frankfurt: 3CM) (OTCPK: CANVF), a leading digital cannabis education and analytics company, whereas Cannvas shall be the exclusive provider of unbiased cannabis education for Liberty Leaf. The agreement calls for Cannvas to provide original evidence-based educational content, progressive learning modules and value-added services to the Liberty Leaf cannabis accessories e-commerce platform, SignaturebyLibertyLeaf.com, through white labeling solutions powered by the Cannvas.Me educational platform.
“We are thrilled to partner with Liberty Leaf to ensure their audiences have easy access to a library of unbiased cannabis education powered by the physician-backed and educator-approved Cannvas.Me digital learning platform,” said Steve Loutskou, Chief Operating Officer, Global Markets, Cannvas MedTech. “As we work toward our goal of becoming the leading third-party arm’s-length resource for unbiased information and education on cannabis, it’s encouraging to establish partnerships with companies like Liberty Leaf who understand the value of educating consumers and empowering them with the information to make beneficial cannabis choices.”
Under the terms of the agreement, Cannvas will provide subscription-based white-label educational services based on its original educational content, created and curated by its independent Medical, Educational and Cannabis Sciences Advisory Boards. Consideration for the services reflected in the agreement comes in the form of a 12-month paid subscription with an annual sum to be reviewed following each year and with ample room for expansion of services and offerings.
Will Rascan, Liberty Leaf’s President and Director, explained, “One of our mandates at Liberty Leaf is to take a leadership role in contributing to the cannabis community. Providing quality education around cannabis through our various platforms, including our Signature site, is a key way of doing that – and now, partnering with Cannvas MedTech, we can go ahead.”
“All the content we put out through Cannvas will be physician-backed and education-approved. That’s very important to us at Liberty Leaf,” Rascan stresses, “because we feel the community deserves, and it’s important for us to deliver, solid, reliable information.”
Rascan adds, “From a business perspective, providing quality content is not only the right thing to do, but differentiates Liberty Leaf in terms of how our brands are positioned.”
Once fully integrated with the Liberty Leaf platform, its audience will be able to access Cannvas.Me educational content from anywhere in the world, and Cannvas expects to work closely with Liberty Leaf’s partner network to source information and collaborate on articles to meet the needs of the communities it serves across Canada.
About Liberty Leaf Holdings Ltd.
Liberty Leaf is a Canadian-based, public company whose focus is to build and support a diversified portfolio of cannabis-sector businesses, including cultivation, processing,
value-added cannabidiol products and accessory products within this dynamic and fast-growing sector.
About Cannvas MedTech Inc.
For further info on the Company please visit https://www.libleaf.com or email firstname.lastname@example.org
On Behalf of the Board
Will Rascan, President & CEO
Liberty Leaf Holdings Ltd.
Toll Free: 1-833-LIB-LEAF (542-5323)
Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.
This news release may contain forward-looking statements based on assumptions and judgments of management regarding future events or results. Such statements are subject to a variety of risks and uncertainties which could cause actual events or results to differ materially from those reflected in the forward-looking statements. The Company disclaims any intention or obligation to revise or update such statements.